PLS3: A Drug Target / Disease Biomarker (G5358)

Target Name: PLS3

NCBI ID: G5358

PLS3

PLS3: A Drug Target / Disease Biomarker

PLS3 (Principally Localized Sequence 3) is a protein that is expressed in various tissues and cells throughout the body. It is a member of the superfamily of leucine-rich repeat (LRR) proteins, which are characterized by the presence of a specific repeat sequence in their amino acid sequence.

PLS3 is unique among LRR proteins in that it is expressed in the nervous system, specifically in the brain and spinal cord. It is also one of the most abundant proteins in the nervous system, making it an attractive target for researchers looking for new drug and biomarker candidates.

The N-terminus of PLS3 contains a unique farnesylated cysteine residue, which is important for its stability and localization to the endoplasmic reticulum (ER). This cysteine residue is also involved in the regulation of the protein's stability and solubility, as well as its interaction with other proteins.

The C-terminus of PLS3 contains a multiple-domain structure that includes a transmembrane region, a cytoplasmic domain, and an amino-terminal region that is involved in protein-protein interactions. The transmembrane region is composed of a unique disulfide-bonded sequence that is specific to PLS3 and is involved in the regulation of its stability.

PLS3 is involved in various cellular processes that are critical for brain development, function, and repair. One of the most well-studied functions of PLS3 is its role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time.

PLS3 is involved in the formation of synapses, the sites of communication between neurons, and is thought to play a role in the regulation of the strength and duration of synaptic connections. It is also involved in the regulation of neurotransmitter release and the modulation of the electrical activity of neurons.

In addition to its role in synaptic plasticity, PLS3 is also involved in the regulation of cellular stress responses, which are critical for maintaining cellular homeostasis in the face of environmental stressors.

PLS3 is a potential drug target because of its unique expression pattern in the nervous system and its involvement in various cellular processes that are critical for brain health and function. It is also a potential biomarker for various neurological disorders, including Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.

In conclusion, PLS3 is a unique and highly-studied protein that is involved in various cellular processes in the nervous system. Its unique expression pattern and involvement in synaptic plasticity, cellular stress responses, and neurotransmission make it an attractive target for researchers looking for new drug and biomarker candidates. Further studies are needed to fully understand the functions of PLS3 and its potential as a drug and biomarker.

Protein Name: Plastin 3

Functions: Actin-bundling protein found in intestinal microvilli, hair cell stereocilia, and fibroblast filopodia. May play a role in the regulation of bone development

The "PLS3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLS3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets